Social network
  • Visit We R Hope page

    We R Hope by Sanofi

  • Fighting dengue ferver

    Fighting dengue ferver

  • Meet Anne-Olivier Bandini: R&D Team Leader, France

  • Isabelle, Type 1 diabetes, France

    Isabelle, Type 1 diabetes, France

    Tools content (print, share, increase/decrease text size):


      Middle area:

      R&D Portfolio

      At the end of July 2016, the R&D pipeline contained 44 pharmaceutical new molecular entities (excluding Life Cycle Management) and vaccine candidates in clinical development of which 14 are in Phase III or have been submitted to the regulatory authorities for approval.


      © Sanofi 2004-2016 - All rights reserved - Update: September 19, 2016

      • Site complies with W3C WCAG 2.0 (new window, in english)